JESÚS FERNANDO
SAN MIGUEL IZQUIERDO
Forscher in der Zeit 1986-2013
Japanese Red Cross Medical Center
Tokio, JapónPublikationen in Zusammenarbeit mit Forschern von Japanese Red Cross Medical Center (2)
2021
2019
-
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458